Ayurcann Holdings Corp.
AYURF
$0.01
-$0.01-40.91%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.38M | 22.31M | 21.39M | 20.94M | 19.84M |
| Total Other Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Revenue | 22.38M | 22.31M | 21.39M | 20.94M | 19.84M |
| Cost of Revenue | 16.25M | 15.31M | 13.98M | 13.52M | 13.20M |
| Gross Profit | 6.13M | 7.01M | 7.41M | 7.41M | 6.64M |
| SG&A Expenses | 8.49M | 8.64M | 8.86M | 8.74M | 8.45M |
| Depreciation & Amortization | 358.60K | 420.70K | 519.20K | 532.50K | 558.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.09M | 24.37M | 23.36M | 22.79M | 22.21M |
| Operating Income | -2.71M | -2.06M | -1.97M | -1.86M | -2.37M |
| Income Before Tax | -3.16M | -2.54M | -2.65M | -2.45M | -2.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.16 | -2.54 | -2.65 | -2.45 | -2.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.16M | -2.54M | -2.65M | -2.45M | -2.93M |
| EBIT | -2.71M | -2.06M | -1.97M | -1.86M | -2.37M |
| EBITDA | -2.19M | -1.47M | -1.33M | -1.11M | -1.56M |
| EPS Basic | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 778.82M | 778.82M | 762.26M | 759.89M | 727.38M |
| Average Diluted Shares Outstanding | 778.82M | 778.82M | 762.26M | 759.89M | 727.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |